Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective
Background: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/9/1817 |
_version_ | 1797536812352143360 |
---|---|
author | Hendricus Nijland Jelle Overbosch Joris J. W. Ploegmakers Thomas C. Kwee Paul C. Jutte |
author_facet | Hendricus Nijland Jelle Overbosch Joris J. W. Ploegmakers Thomas C. Kwee Paul C. Jutte |
author_sort | Hendricus Nijland |
collection | DOAJ |
description | Background: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous tumors (atypical cartilaginous tumors and enchondroma) was performed. The results, complications, and development of halo dimensions over time are presented. Methods: Data of all patients with an RFA procedure for an ACT between 2007–2018 were included. Ablation area is visible on baseline MRI, 3 months post-procedure, and is called halo. Volume was measured on MR images and compared to different follow-up moments to determine the effect of time on halo volume. Follow-up was carried out 3 months and 1, 2, 5, and 7 years after the procedure. Occurrence of complications and recurrences were assessed. Results: Of the 137 patients included, 82 were analyzed. Mean follow-up time was 43.6 months. Ablation was complete in 73 cases (89.0%). One late complication occurred, while no recurrences were seen. Halo dimensions of height, width, and depth decreased with a similar rate, 21.5% on average in the first year. Subsequently, this decrease in halo size continues gradually during follow-up, indicating bone revitalization. Conclusion: RFA is a safe and effective treatment in low-grade cartilaginous tumors with an initial success rate of 89.0%. Extended follow-up shows no local recurrences and gradual substitution of the halo with normal bone. |
first_indexed | 2024-03-10T12:06:09Z |
format | Article |
id | doaj.art-dce133823c5b4f09b2d3dd60ee9c165a |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-10T12:06:09Z |
publishDate | 2021-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-dce133823c5b4f09b2d3dd60ee9c165a2023-11-21T16:35:28ZengMDPI AGJournal of Clinical Medicine2077-03832021-04-01109181710.3390/jcm10091817Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and EffectiveHendricus Nijland0Jelle Overbosch1Joris J. W. Ploegmakers2Thomas C. Kwee3Paul C. Jutte4Department of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Radiology, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsDepartment of Orthopaedic Surgery, University Medical Center Groningen, 9713GZ Groningen, The NetherlandsBackground: Radiofrequency ablation (RFA) is a minimally invasive alternative in the treatment of bone tumors. Long-term follow-up has not been described in current literature. Detailed analysis of mid- and long-term follow-up after RFA treatment for a cohort of patients with low-grade cartilaginous tumors (atypical cartilaginous tumors and enchondroma) was performed. The results, complications, and development of halo dimensions over time are presented. Methods: Data of all patients with an RFA procedure for an ACT between 2007–2018 were included. Ablation area is visible on baseline MRI, 3 months post-procedure, and is called halo. Volume was measured on MR images and compared to different follow-up moments to determine the effect of time on halo volume. Follow-up was carried out 3 months and 1, 2, 5, and 7 years after the procedure. Occurrence of complications and recurrences were assessed. Results: Of the 137 patients included, 82 were analyzed. Mean follow-up time was 43.6 months. Ablation was complete in 73 cases (89.0%). One late complication occurred, while no recurrences were seen. Halo dimensions of height, width, and depth decreased with a similar rate, 21.5% on average in the first year. Subsequently, this decrease in halo size continues gradually during follow-up, indicating bone revitalization. Conclusion: RFA is a safe and effective treatment in low-grade cartilaginous tumors with an initial success rate of 89.0%. Extended follow-up shows no local recurrences and gradual substitution of the halo with normal bone.https://www.mdpi.com/2077-0383/10/9/1817percutaneousablationlow-grade cartilaginous tumorhaloresultscomplications |
spellingShingle | Hendricus Nijland Jelle Overbosch Joris J. W. Ploegmakers Thomas C. Kwee Paul C. Jutte Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective Journal of Clinical Medicine percutaneous ablation low-grade cartilaginous tumor halo results complications |
title | Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective |
title_full | Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective |
title_fullStr | Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective |
title_full_unstemmed | Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective |
title_short | Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective |
title_sort | long term halo follow up confirms less invasive treatment of low grade cartilaginous tumors with radiofrequency ablation to be safe and effective |
topic | percutaneous ablation low-grade cartilaginous tumor halo results complications |
url | https://www.mdpi.com/2077-0383/10/9/1817 |
work_keys_str_mv | AT hendricusnijland longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective AT jelleoverbosch longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective AT jorisjwploegmakers longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective AT thomasckwee longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective AT paulcjutte longtermhalofollowupconfirmslessinvasivetreatmentoflowgradecartilaginoustumorswithradiofrequencyablationtobesafeandeffective |